Please login to the form below
Actavis
The Top Pharma List rankings are compiled from GlobalData's
pharmaceutical revenue figures, which are based on prescription medicine
sales, including generics drugs.
Sanofi patent case win holds off generic rivals for key cancer drug
Companies including Actavis and Mylan have received tentative US Food and Drug Administration (FDA) approvals for copies of Jevtana in recent years.
Teva wins FDA OK for crucial migraine drug
order to pay down a very high level of debt stemming from its $39bn acquisition of Allergan’s generics business Actavis in 2015.
Axovant poaches Allergan’s and Teva’s chief medical and science officers
Most recently, Corcoran served as chief medical officer at Allergan and before that he was Actavis’ chief medical officer.
Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more
The $64bn sum makes the deal the biggest pharma M&A transaction since Actavis bought Allergan in 2015 for $70.5bn.
Shire warms to Takeda’s latest offer, extending deadline
Analysts suggest however that negative sentiment could still scupper a deal that is by far the largest ever undertaken by the company - and the biggest in pharma since the $70bn
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- Vaccine developers call on FDA to offer clarity on COVID-19 trials
- FDA sets November date for expert panel review of Biogen’s aducanumab
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- Novartis weathers the COVID-19 storm in Q3, lifts outlook
- Pharma, Technology, and Healthcare in the New Normal
- Solving the Caregiver Crisis Through Technology
- Therapeutic VR for Managing Pain & Improving Patient Outcomes
- Fishawack Health launches global ‘PsoriasIS NOT CONTAGIOUS’ mask campaign for World Psoriasis Day 2020
- The impact of COVID-19 on cancer care
- UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
PMHub
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...
Latest intelligence
- The science of the deal
- Business development is more like child-raising than you might think...
- The other side of … rheumatoid arthritis
- For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
- How to lessen site burden with a targeted patient recruitment strategy
- Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Quick links
Infographics
